Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Ist das schon die Pressearbeit von lifesciadvisors?

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Oct 08, 2021 2:27pm

210 Views

Post# 33989797

RE:Ist das schon die Pressearbeit von lifesciadvisors?

The only things steaming up are your underpants Chucky. See where deals are on that priority list? Last place @ Number 5. Keep waiting and keep dreaming. Life Science getting paid quarter million to re-work existing press releases and now re-working existing presentations. Another fantastic deal made by the one and only Spillup Tolekis-your-money-goodbye.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec